Takeda Pharmaceutical Company Limited

Healthcare

NYSE:TAK · New York Stock Exchange

Market Cap $50.48B Beta 0.09 P/E (TTM) 41.4

$15.98 +0.66%

+$0.11 today

52W Low $12.99High $18.90

Vol 2.52M · Avg 3.09M

EPS (TTM)$122.72

Div Yield3.94%

Drug Manufacturers - Specialty & Generic

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+9.17%

Period High

$18.77

Period Low

$13.01

Latest

$15.96

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Becton, Dickinson and Company

NYSE:BDX

$52.79B

Cardinal Health, Inc.

NYSE:CAH

$52.42B

Edwards Lifesciences Corporation

NYSE:EW

$48.82B

Haleon plc

NYSE:HLN

$40.28B

Agilent Technologies, Inc.

NYSE:A

$36.54B

Alcon Inc.

NYSE:ALC

$32.50B

IQVIA Holdings Inc.

NYSE:IQV

$29.86B

ResMed Inc.

NYSE:RMD

$28.05B

Veeva Systems Inc.

NYSE:VEEV

$25.78B

Insmed Incorporated

NASDAQ:INSM

$21.25B

What is the latest TAK filing?

The latest filing shown is 6-K dated Jun 9, 2026.

How many recent filings does TAK have?

Intrinsic Alpha currently shows 20 recent filings for TAK.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.